COVID-19 and the Rise of Participatory SIGINT: An Examination of the Rise in Government Surveillance Through Mobile Applications.


Journal

American journal of public health
ISSN: 1541-0048
Titre abrégé: Am J Public Health
Pays: United States
ID NLM: 1254074

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 16 10 2020
medline: 15 12 2020
entrez: 15 10 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has triggered a significant growth in government surveillance techniques globally, primarily through the use of cell phone applications. However, although these applications can have actionable effects on public health efforts to control pandemics, the participatory or voluntary nature of these measures is obscuring the relationship between health information and traditional government surveillance techniques, potentially preventing effective oversight. Public health measures have traditionally been resistant to the integration of government-led intelligence techniques, such as signals intelligence (SIGINT), because of ethical and legal issues arising from the nature of surveillance techniques.We explore this rise of participatory SIGINT and its nature as an extension of biosurveillance through 3 drivers: the rise of surveillance capitalism, the exploitation of a public health crisis to obscure state of exception politics with a moral imperative, and the historically enduring nature of emergency-implemented surveillance measures.We conclude that although mobile applications may indeed be useful in containing pandemics, they should be subject to similar oversight and regulation as other government intelligence collection techniques.

Identifiants

pubmed: 33058704
doi: 10.2105/AJPH.2020.305912
pmc: PMC7661974
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1780-1785

Commentaires et corrections

Type : CommentIn

Références

Z Gesundh Wiss. 2018;26(5):509-514
pubmed: 30294522
Nat Commun. 2019 Jul 23;10(1):3069
pubmed: 31337762
Science. 2020 May 8;368(6491):
pubmed: 32234805

Auteurs

Rose Bernard (R)

All authors are with the Conflict and Health Research Group, Kings College London, London, UK.

Gemma Bowsher (G)

All authors are with the Conflict and Health Research Group, Kings College London, London, UK.

Richard Sullivan (R)

All authors are with the Conflict and Health Research Group, Kings College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH